DK1093380T3 - Komponent B som angiogent middel i kombination med humane vækstfaktorer - Google Patents

Komponent B som angiogent middel i kombination med humane vækstfaktorer

Info

Publication number
DK1093380T3
DK1093380T3 DK99934563T DK99934563T DK1093380T3 DK 1093380 T3 DK1093380 T3 DK 1093380T3 DK 99934563 T DK99934563 T DK 99934563T DK 99934563 T DK99934563 T DK 99934563T DK 1093380 T3 DK1093380 T3 DK 1093380T3
Authority
DK
Denmark
Prior art keywords
combination
human growth
component
growth factors
angiogenic agent
Prior art date
Application number
DK99934563T
Other languages
Danish (da)
English (en)
Inventor
Marina Ziche
Silvia Donini
Francesco Borrelli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1093380T3 publication Critical patent/DK1093380T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK99934563T 1998-07-09 1999-07-02 Komponent B som angiogent middel i kombination med humane vækstfaktorer DK1093380T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98112775 1998-07-09
PCT/EP1999/004605 WO2000002579A2 (fr) 1998-07-09 1999-07-02 Compose b en tant qu'agent angiogenique combine a des facteurs de croissance humaine

Publications (1)

Publication Number Publication Date
DK1093380T3 true DK1093380T3 (da) 2003-01-27

Family

ID=8232248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934563T DK1093380T3 (da) 1998-07-09 1999-07-02 Komponent B som angiogent middel i kombination med humane vækstfaktorer

Country Status (12)

Country Link
US (2) US6855684B2 (fr)
EP (1) EP1093380B1 (fr)
JP (1) JP2002520292A (fr)
AT (1) ATE224200T1 (fr)
AU (1) AU765600B2 (fr)
CA (1) CA2336773C (fr)
DE (1) DE69903037T2 (fr)
DK (1) DK1093380T3 (fr)
ES (1) ES2184480T3 (fr)
IL (2) IL140778A0 (fr)
PT (1) PT1093380E (fr)
WO (1) WO2000002579A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU765600B2 (en) * 1998-07-09 2003-09-25 Merck Serono Sa Compound B as angiogenic agent in combination with human growth factors
WO2002022176A1 (fr) 2000-09-15 2002-03-21 Genvec, Inc. Procede de modulation de neovascularisation
AU2004229237B2 (en) 2003-04-16 2009-06-04 Merck Serono Sa Use of SLURP-1 for treating diseases related to acetylcholine receptors dysfunction
US20060128939A1 (en) * 2004-12-03 2006-06-15 Vijayendra Kumar One pot process for making polymeric antioxidants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
EA001077B1 (ru) * 1996-04-24 2000-10-30 Апплайд Резеч Системз Арс Холдинг Н.В. Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
AU765600B2 (en) * 1998-07-09 2003-09-25 Merck Serono Sa Compound B as angiogenic agent in combination with human growth factors

Also Published As

Publication number Publication date
AU5030699A (en) 2000-02-01
JP2002520292A (ja) 2002-07-09
US7223732B2 (en) 2007-05-29
PT1093380E (pt) 2003-01-31
CA2336773C (fr) 2009-12-15
DE69903037D1 (de) 2002-10-24
AU765600B2 (en) 2003-09-25
DE69903037T2 (de) 2003-06-05
CA2336773A1 (fr) 2000-01-20
WO2000002579A3 (fr) 2000-02-24
US20010031733A1 (en) 2001-10-18
WO2000002579A2 (fr) 2000-01-20
IL140778A (en) 2008-03-20
ATE224200T1 (de) 2002-10-15
EP1093380A2 (fr) 2001-04-25
US6855684B2 (en) 2005-02-15
US20050153892A1 (en) 2005-07-14
ES2184480T3 (es) 2003-04-01
EP1093380B1 (fr) 2002-09-18
IL140778A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
DK1071417T3 (da) Anvendelse af cannabidiol som anti-inflammatorisk middel
TR200002759T2 (tr) Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı.
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
SE9701162D0 (sv) New use II
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
DK1235571T3 (da) Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
DE69932510D1 (de) Vaskularisierungsinhibitoren
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
PT1089704E (pt) Locao tricologica para aplicacao topica
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
DK261490D0 (da) New pharmaceutical compound
PT1112083E (pt) Uso de um factor angiogenico para o tratamento de angiopatias microvasculares
AR025330A1 (es) Combinacion de sustancias activas con clonidina
DK1093380T3 (da) Komponent B som angiogent middel i kombination med humane vækstfaktorer
BRPI0209619B8 (pt) agente promotor de crescimento capilar
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
NO20003758L (no) Trekonserveringsmidler
DK1660100T3 (da) Anti-tumorformuleringer der omfatter defibrotid alene eller i kombination med andre anti-tumormidler
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša